Preliminary evidence of blunted humoral response to SARS-CoV-2 mRNA vaccine in multiple sclerosis patients treated with ocrelizumab - Concepedia

Concepedia

Publication | Open Access

Preliminary evidence of blunted humoral response to SARS-CoV-2 mRNA vaccine in multiple sclerosis patients treated with ocrelizumab

DOI Full Paper Access

46

Citations

6

References

2021

Year

Antonio Gallo, Rocco Capuano, Giovanna Donnarumma, Alvino Bisecco, Elena Grimaldi, Miriana Conte, Alessandro d’Ambrosio, Nicola Coppola, Massimiliano Galdiero, Gioacchino Tedeschi

Neurological Sciences

VaccinationMultiple Sclerosis PatientsVaccine DevelopmentHumoral ResponseImmunologyPreliminary EvidenceSars-cov-2 Mrna VaccineMultiple SclerosisImmunotherapyMedicine

References

	Year	Citations

Page 1

Page 1